A Study of Teduglutide in Japanese People With Short Bowel Syndrome

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Short Bowel Syndrome
Interventions
DRUG

Teduglutide

Teduglutide 0.05 mg/kg SC injection

Trial Locations (2)

Unknown

NOT_YET_RECRUITING

Takeda Selected Site, Tokyo

RECRUITING

Takeda selected site, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY